As the inhibition of proteins of DDR pathways is gaining importance in various cancer treatments [18], we focused on melanoma cancer cells and inhibition of DDR through targeting the above-mentioned proteins ATR and ATM by using the ATM inhibitor (ATMi) AZD0156 and ATR inhibitor (ATRi) VE-822. This evidence concerns the gene ATM and cancer.